Ahn-Gook Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Ahn-Gook Pharmaceutical has a total shareholder equity of ₩151.7B and total debt of ₩17.3B, which brings its debt-to-equity ratio to 11.4%. Its total assets and total liabilities are ₩238.6B and ₩86.9B respectively. Ahn-Gook Pharmaceutical's EBIT is ₩5.1B making its interest coverage ratio -20.6. It has cash and short-term investments of ₩35.4B.
Key information
11.4%
Debt to equity ratio
₩17.30b
Debt
| Interest coverage ratio | -20.6x |
| Cash | ₩35.45b |
| Equity | ₩151.67b |
| Total liabilities | ₩86.93b |
| Total assets | ₩238.60b |
Recent financial health updates
Recent updates
Are Dividend Investors Making A Mistake With Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Apr 02
Ahn-Gook Pharmaceutical (KOSDAQ:001540) Shareholders Booked A 29% Gain In The Last Year
Mar 07Is Ahn-Gook Pharmaceutical (KOSDAQ:001540) Using Too Much Debt?
Feb 14Do Insiders Own Lots Of Shares In Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Jan 19Dividend Investors: Don't Be Too Quick To Buy Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Upcoming Dividend
Dec 24A Look At The Fair Value Of Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
Dec 10Key Things To Consider Before Buying Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Dividend
Nov 18
Financial Position Analysis
Short Term Liabilities: A001540's short term assets (₩135.4B) exceed its short term liabilities (₩78.2B).
Long Term Liabilities: A001540's short term assets (₩135.4B) exceed its long term liabilities (₩8.7B).
Debt to Equity History and Analysis
Debt Level: A001540 has more cash than its total debt.
Reducing Debt: A001540's debt to equity ratio has reduced from 13.6% to 11.4% over the past 5 years.
Debt Coverage: A001540's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A001540 earns more interest than it pays, so coverage of interest payments is not a concern.